Stockreport

SAB BIO Announces Oversubscribed $175 Million Private Placement

SAB Biotherapeutics, Inc.  (SABS) 
PDF Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce S [Read more]